Technical Analysis for VCEL - Vericel Corporation

Grade Last Price % Change Price Change
grade A 17.75 -1.11% -0.20
VCEL closed up 2.34 percent on Thursday, January 17, 2019, on 84 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical VCEL trend table...

Date Alert Name Type % Chg
Jan 17 Outside Day Range Expansion -1.11%
Jan 15 180 Bullish Setup Bullish Swing Setup 0.17%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.17%
Jan 15 Outside Day Range Expansion 0.17%
Jan 15 Overbought Stochastic Strength 0.17%
Jan 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.35%
Jan 14 Overbought Stochastic Strength 4.35%
Jan 14 Down 3 Days in a Row Weakness 4.35%
Jan 14 Gapped Down Weakness 4.35%
Jan 11 Stochastic Sell Signal Bearish -0.06%

Older signals for VCEL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vericel Corporation, a commercial-stage biopharmaceutical company, focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets two autologous cell therapy products in the United States, including Carticel (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee; and Epicel (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area. The company is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee; and ixmyelocel-T, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. The company, formerly known as Aastrom Biosciences, Inc., was founded in 1989 and is headquartered in Cambridge, Massachusetts.
Is VCEL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.87
52 Week Low 6.0
Average Volume 1,056,455
200-Day Moving Average 13.3571
50-Day Moving Average 16.8842
20-Day Moving Average 16.9745
10-Day Moving Average 17.823
Average True Range 0.9387
ADX 13.39
+DI 22.4577
-DI 19.6179
Chandelier Exit (Long, 3 ATRs ) 15.8339
Chandelier Exit (Short, 3 ATRs ) 16.8161
Upper Bollinger Band 19.3658
Lower Bollinger Band 14.5832
Percent B (%b) 0.7
BandWidth 28.175204
MACD Line 0.383
MACD Signal Line 0.375
MACD Histogram 0.008
Fundamentals Value
Market Cap 589.17 Million
Num Shares 32.8 Million
EPS -1.04
Price-to-Earnings (P/E) Ratio -17.26
Price-to-Sales 2.75
Price-to-Book 10.56
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.06
Resistance 3 (R3) 19.02 18.61 18.88
Resistance 2 (R2) 18.61 18.33 18.63 18.81
Resistance 1 (R1) 18.28 18.15 18.45 18.32 18.75
Pivot Point 17.87 17.87 17.95 17.89 17.87
Support 1 (S1) 17.54 17.59 17.71 17.58 17.15
Support 2 (S2) 17.13 17.41 17.15 17.09
Support 3 (S3) 16.80 17.13 17.03
Support 4 (S4) 16.84